Table 2.
Distribution of Sociodemographic and Clinical Characteristics Among Men (n = 1,441) in the Cardiovascular Health Study Sample by Quintiles of Body Mass Index at Baseline, United States, 1989–1990 or 1992–1993
| Characteristic | BMI, kg/m2 |
||||||||||||||
| <23.4 |
23.4–25.2 |
25.3–26.8 |
26.9–29.1 |
≥29.2 |
|||||||||||
| Mean (SD) | % | Median (IQR) | Mean (SD) | % | Median (IQR) | Mean (SD) | % | Median (IQR) | Mean (SD) | % | Median (IQR) | Mean (SD) | % | Median (IQR) | |
| Age, years | 73.9 (6.1) | 72.7 (5.4) | 72.9 (5.4) | 72.5 (5.2) | 71.7 (5.0) | ||||||||||
| Black | 11.8 | 10.8 | 15.3 | 15.6 | 17.4 | ||||||||||
| Education | |||||||||||||||
| Less than high school | 28.0 | 31.9 | 28.8 | 30.6 | 30.2 | ||||||||||
| High school graduate | 23.2 | 22.2 | 22.6 | 22.9 | 26.7 | ||||||||||
| College or higher | 48.8 | 45.8 | 48.6 | 46.5 | 43.1 | ||||||||||
| Smoking status | |||||||||||||||
| Never | 31.8 | 30.2 | 34.4 | 34.0 | 35.4 | ||||||||||
| Former | 52.3 | 55.2 | 55.2 | 53.8 | 57.6 | ||||||||||
| Current | 15.9 | 14.6 | 10.4 | 12.2 | 6.9 | ||||||||||
| Alcoholic drinks/week | |||||||||||||||
| 0 | 43.6 | 36.5 | 38.5 | 36.1 | 47.2 | ||||||||||
| <7 | 35.3 | 41.7 | 39.2 | 40.6 | 36.8 | ||||||||||
| 7–13 | 9.3 | 9.0 | 10.8 | 9.7 | 5.9 | ||||||||||
| ≥14 | 11.8 | 12.9 | 11.5 | 13.5 | 10.1 | ||||||||||
| Self-reported health | |||||||||||||||
| Excellent | 18.7 | 20.1 | 19.1 | 22.9 | 14.0 | ||||||||||
| Very good | 31.1 | 28.1 | 29.2 | 24.3 | 26.2 | ||||||||||
| Good | 32.9 | 37.2 | 33.0 | 37.2 | 42.7 | ||||||||||
| Fair | 15.6 | 10.8 | 16.0 | 14.9 | 15.0 | ||||||||||
| Poor | 1.7 | 3.8 | 2.8 | 0.7 | 2.1 | ||||||||||
| Weight change from age 50 years, kg | −4.1 (5.3) | −0.7 (6.0) | 0.9 (6.2) | 3.1 (7.6) | 6.6 (10.1) | ||||||||||
| Physical activity, kcal | 1,103 (416–2,501) | 1,080 (415–2,455) | 1,120 (432–2,471) | 1,080 (405–2,700) | 840 (268–1,860) | ||||||||||
| Estrogen use | |||||||||||||||
| Never | —a | — | — | — | — | ||||||||||
| Past | — | — | — | — | — | ||||||||||
| Current | — | — | — | — | — | ||||||||||
| Aspirin use >2 days in past 2 weeks | 28.4 | 29.2 | 30.9 | 30.9 | 30.9 | ||||||||||
| Systolic blood pressure, mm Hg | 134.2 (22.8) | 133.6 (20.7) | 135.3 (19.9) | 135.8 (20.3) | 139.5 (20.2) | ||||||||||
| Diastolic blood pressure, mm Hg | 70.9 (11.3) | 71.4 (11.7) | 73.3 (11.8) | 73.7 (10.7) | 75.6 (10.9) | ||||||||||
| Hypertension | 47.8 | 45.8 | 50.0 | 56.9 | 66.7 | ||||||||||
| Use of antihypertensive medication | 25.6 | 27.8 | 30.9 | 42.0 | 46.2 | ||||||||||
| Impaired fasting glucose | 36.3 | 39.9 | 43.8 | 49.0 | 47.9 | ||||||||||
| Diabetes | 10.0 | 11.1 | 13.2 | 17.0 | 28.5 | ||||||||||
| Glucose, mg/dL | 106.1 (31.8) | 109.5 (35.5) | 107.2 (25.1) | 112.2 (28.6) | 122.1 (41.3) | ||||||||||
| Insulin, IU/mL | 12.7 (24.7) | 14.4 (24.6) | 14.2 (8.7) | 16.1 (9.8) | 22.0 (26.8) | ||||||||||
| Total cholesterol, mg/dL | 193.7 (34.4) | 196.8 (34.5) | 202.9 (36.9) | 201.7 (35.4) | 200.6 (38.5) | ||||||||||
| LDL cholesterol, mg/dL | 118.3 (31.3) | 122.7 (32.0) | 125.9 (33.8) | 126.9 (33.7) | 125.9 (35.9) | ||||||||||
| HDL cholesterol, mg/dL | 53.7 (14.3) | 48.6 (11.3) | 50.8 (14.1) | 46.4 (11.7) | 45.8 (10.6) | ||||||||||
| Triglycerides, mg/dL | 98 (78–129) | 113 (87–149) | 113 (88–155) | 127 (95–180) | 130 (103–172) | ||||||||||
| Serum creatinine, mg/dL | 1.19 (0.25) | 1.18 (0.30) | 1.21 (0.29) | 1.22 (0.26) | 1.20 (0.31) | ||||||||||
| hsCRP, mg/L | 1.6 (0.7–3.1) | 2.0 (1.0–3.7) | 2.0 (1.1–3.7) | 2.3 (1.3–4.1) | 2.8 (1.6–4.8) | ||||||||||
Abbreviations: BMI, body mass index; HDL, high density lipoprotein; hsCRP, high sensitivity C-reactive protein; IQR, intrerquartile range; LDL, low density lipoprotein; SD, standard deviation.
a
—, not applicable.